Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Sharp Phillip A, Director. Insider active across 2 companies, notably Vir Biotechnology, Inc.. In total, 7 disclosures have been published. Activity tracked since 21 May 2021. The latest transaction was filed on 23 January 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Phillip A. Sharp is a Board Member at Vir Biotechnology, Inc. and ALNYLAM PHARMACEUTICALS, INC. He brings his expertise in the biopharmaceutical field, contributing to the strategy and governance of the companies. His experience is an asset for the development of these firms.